WAYNE, PA: Shire Pharmaceuticals announced its consumer-driven launch for Vyvanse, an ADHD (attention deficit hyperactivity disorder) drug for adults, on July 23. The FDA approved the drug for adults aged 18 to 55 in April, and for children aged 6 to 12 in July 2007.
PR efforts kicked off with a press conference at the Savannah College of Art and Design in Atlanta, led by Ty Pennington, patient spokesman and host of Extreme Makeover: Home Edition, who announced that a ...